A recent study by Rutgers Health researchers reveals a concerning surge in sedative, hypnotic, and anxiolytic use disorders among adolescents and young adults in the United States. The study, spanning from 2001 to 2019, found a threefold increase in these diagnoses among adolescents and a fivefold increase among young adults. This alarming trend highlights the need for a multifaceted approach to address the issue.
The study points to several factors contributing to this rise, including increased access to these medications, both through prescriptions and nonmedical means. The study also suggests that heightened awareness and improved diagnostic practices may be playing a role.
The study also found a high comorbidity rate, with many individuals diagnosed with sedative use disorders also having other substance use disorders, particularly cannabis use disorder among adolescents and opioid use disorder among young adults. This underscores the need for integrated treatment strategies that address both the primary disorder and any co-occurring issues.
The findings call for a collective effort to address the issue, including cautious prescribing practices, education about the risks of nonmedical use, and access to support services. It is crucial to address the stigma surrounding these disorders and promote responsible use of these medications.